| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| SLP(L) | 65 | 34.6% | 0.19 | 74 | 51.4% |
| AL(L) | 82 | 43.6% | -inf | 0 | 0.0% |
| LH(L) | 29 | 15.4% | 0.73 | 48 | 33.3% |
| SCL(L) | 6 | 3.2% | 0.74 | 10 | 6.9% |
| PLP(L) | 3 | 1.6% | 2.00 | 12 | 8.3% |
| CentralBrain-unspecified | 3 | 1.6% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns M_vPNml54 | % In | CV |
|---|---|---|---|---|---|
| ORN_DC2 | 13 | ACh | 40 | 24.4% | 0.8 |
| CB1752 (L) | 2 | ACh | 19 | 11.6% | 0.8 |
| LHAV6i2_b (L) | 1 | ACh | 14 | 8.5% | 0.0 |
| M_vPNml77 (L) | 2 | GABA | 8 | 4.9% | 0.8 |
| LHPV6a9_b (L) | 2 | ACh | 8 | 4.9% | 0.5 |
| VM7v_adPN (L) | 2 | ACh | 7 | 4.3% | 0.4 |
| CB1981 (L) | 1 | Glu | 5 | 3.0% | 0.0 |
| VM5d_adPN (L) | 2 | ACh | 5 | 3.0% | 0.2 |
| ORN_VM7v | 2 | ACh | 4 | 2.4% | 0.5 |
| CB3383 (L) | 1 | ACh | 3 | 1.8% | 0.0 |
| CB1604 (L) | 1 | ACh | 3 | 1.8% | 0.0 |
| lLN1_bc (L) | 3 | ACh | 3 | 1.8% | 0.0 |
| HRN_VP4 | 1 | ACh | 2 | 1.2% | 0.0 |
| LHPV4b3 (L) | 1 | Glu | 2 | 1.2% | 0.0 |
| CB1782 (L) | 1 | ACh | 2 | 1.2% | 0.0 |
| SLP341_a (L) | 1 | ACh | 2 | 1.2% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 2 | 1.2% | 0.0 |
| v2LN41 (R) | 2 | unc | 2 | 1.2% | 0.0 |
| ORN_VA6 | 2 | ACh | 2 | 1.2% | 0.0 |
| CB1824 (L) | 2 | GABA | 2 | 1.2% | 0.0 |
| CB4117 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| CB2133 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| v2LN3A (L) | 1 | unc | 1 | 0.6% | 0.0 |
| M_vPNml69 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| CB2208 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB0973 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| SLP337 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB2920 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| LHAV2c1 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB2600 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| M_vPNml87 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| M_vPNml80 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| LHAD1d1 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB3228 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| LHPV4c3 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| M_vPNml76 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| v2LN41 (L) | 1 | unc | 1 | 0.6% | 0.0 |
| LHPV4c4 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB1387 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CL340 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| lLN2T_b (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| M_vPNml50 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| VA1v_vPN (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| DN1a (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 1 | 0.6% | 0.0 |
| lLN2T_e (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| DC1_adPN (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| il3LN6 (R) | 1 | GABA | 1 | 0.6% | 0.0 |
| LHPV6q1 (L) | 1 | unc | 1 | 0.6% | 0.0 |
| downstream partner | # | NT | conns M_vPNml54 | % Out | CV |
|---|---|---|---|---|---|
| LHPV6i2_a (L) | 1 | ACh | 29 | 12.4% | 0.0 |
| CB3081 (L) | 2 | ACh | 17 | 7.3% | 0.5 |
| LHPV4c1_c (L) | 4 | Glu | 16 | 6.9% | 0.4 |
| CB3556 (L) | 4 | ACh | 13 | 5.6% | 0.3 |
| CB3173 (L) | 2 | ACh | 12 | 5.2% | 0.0 |
| CB3055 (L) | 3 | ACh | 9 | 3.9% | 0.5 |
| CB1617 (L) | 2 | Glu | 7 | 3.0% | 0.4 |
| DN1a (L) | 1 | Glu | 6 | 2.6% | 0.0 |
| LHAV4d1 (L) | 3 | unc | 6 | 2.6% | 0.7 |
| LHPD5a1 (L) | 1 | Glu | 5 | 2.1% | 0.0 |
| LHPV4b3 (L) | 2 | Glu | 5 | 2.1% | 0.6 |
| LHPV4g2 (L) | 3 | Glu | 5 | 2.1% | 0.6 |
| CB1333 (L) | 2 | ACh | 5 | 2.1% | 0.2 |
| SLP337 (L) | 2 | Glu | 5 | 2.1% | 0.2 |
| CB1901 (L) | 3 | ACh | 5 | 2.1% | 0.3 |
| CB1154 (L) | 1 | Glu | 4 | 1.7% | 0.0 |
| SLP269 (L) | 1 | ACh | 4 | 1.7% | 0.0 |
| CB1884 (L) | 2 | Glu | 4 | 1.7% | 0.0 |
| CB1846 (L) | 1 | Glu | 3 | 1.3% | 0.0 |
| CB4133 (L) | 1 | Glu | 3 | 1.3% | 0.0 |
| LHAV3a1_c (L) | 1 | ACh | 3 | 1.3% | 0.0 |
| SLP210 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| CB2517 (L) | 1 | Glu | 2 | 0.9% | 0.0 |
| CB4123 (L) | 1 | Glu | 2 | 0.9% | 0.0 |
| CB3318 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| LHPV6a9_b (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| M_vPNml53 (L) | 1 | GABA | 2 | 0.9% | 0.0 |
| LHPV5g2 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| SLP402_b (L) | 1 | Glu | 2 | 0.9% | 0.0 |
| CB4084 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| LHPV6f5 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| SLP112 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| CB4085 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| LHPV5a3 (L) | 2 | ACh | 2 | 0.9% | 0.0 |
| CB0943 (L) | 2 | ACh | 2 | 0.9% | 0.0 |
| LHPV5h2_a (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB2904 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB4130 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHAV3n1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CL094 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB3293 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SMP416 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP374 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| SLP322 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB4129 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHPD4b1 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHPV6a1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1874 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHPV6h1_b (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV5a1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB0973 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB2920 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB1160 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB1178 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHPV6i1_a (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP315 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB1735 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB3005 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB3556 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1201 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP089 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHPV4c2 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB4139 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAD1b3 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB2467 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP365 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB0386 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB1387 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP458 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHCENT13_b (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV6m1 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHAV2n1 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| SLP206 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
